← Leaderboards
Benjamin Levi
University Of Michigan At Ann Arbor
$10,166,720
Attributed
$13,086,538
Total exposure
10
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.4M · FY2009–25$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$13,086,538 · 10
By mechanism
R01$10,593,869 · 5
R61$786,192 · 1
K08$784,640 · 1
R33$410,000 · 1
R21$400,693 · 1
F32$111,144 · 1
Top collaborators
- Aaron W James5 shared
- Katherine Ann Gallagher4 shared
- Shang Ma1 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Scott J Hollister$15,281,931
- Eva L Feldman$26,770,746
- Nan E Hatch$3,757,136
- Chia-Ying Lin$3,242,520
- Steven P. Schwendeman$6,555,011
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoPreventSignal TransductionHeterotopic OssificationSiteBoneCellsPathway InteractionsBurn InjuryInjuryOsteogenesisPathologicOperative Surgical ProceduresMouse ModelJointsMusculoskeletal InjuryMediatingTraumaMesenchymal Stem CellsExcisionInsightHip Replacement ArthroplastyGeneticPrevention
Grant awards (37)
Targeting jmjd3 mitigates heterotopic ossification$597,156
R01 · FY2025 · AR
Unraveling the role of PIEZO mediated mechanosensory signaling in pediatric clubfoot deformity repair$400,693
R21 · FY2025 · AR · contact PI
Impacts of mechanosensation and matrix architecture on cell fate specification in traumatic heterotopic ossification$398,253
R01 · FY2025 · AR · contact PI
Targeting jmjd3 mitigates heterotopic ossification$597,156
R01 · FY2024 · AR
Impact of peripheral nerves on mesenchymal cell fate in extremity trauma$576,704
R01 · FY2024 · AR · contact PI
Impacts of mechanosensation and matrix architecture on cell fate specification in traumatic heterotopic ossification$441,016
R01 · FY2024 · AR · contact PI
Impact of peripheral nerves on mesenchymal cell fate in extremity trauma$593,021
R01 · FY2023 · AR · contact PI
Impact of peripheral nerves on mesenchymal cell fate in extremity trauma$589,600
R01 · FY2023 · AR · contact PI
Impacts of mechanosensation and matrix architecture on cell fate specification in traumatic heterotopic ossification$433,381
R01 · FY2023 · AR · contact PI
Neutrophil Biomarker and neutrophil targeted therapy to predict and prevent heterotopic ossification$410,000
R33 · FY2023 · AR · contact PI
Impacts of mechanosensation and matrix architecture on cell fate specification in traumatic heterotopic ossification$139,195
R01 · FY2023 · AR · contact PI
Targeting jmjd3 mitigates heterotopic ossification$609,471
R01 · FY2022 · AR
Impact of peripheral nerves on mesenchymal cell fate in extremity trauma$602,910
R01 · FY2022 · AR · contact PI
Impacts of mechanosensation and matrix architecture on cell fate specification in traumatic heterotopic ossification$435,118
R01 · FY2022 · AR · contact PI
Impacts of mechanosensation and matrix architecture on cell fate specification in traumatic heterotopic ossification - diversity supplement$127,595
R01 · FY2022 · AR · contact PI
Targeting jmjd3 mitigates heterotopic ossification$643,472
R01 · FY2021 · AR
Impact of peripheral nerves on mesenchymal cell fate in extremity trauma$629,454
R01 · FY2021 · AR · contact PI
Impacts of mechanosensation and matrix architecture on cell fate specification in traumatic heterotopic ossification$428,360
R01 · FY2021 · AR · contact PI
Neutrophil Biomarker and neutrophil targeted therapy to predict and prevent heterotopic ossification$377,442
R61 · FY2021 · AR · contact PI
Targeting Molecular and Cellular Mediators of Inflammation to Prevent Pathologic Cell Differentiation and Heterotopic Ossific$287,769
R01 · FY2021 · AR · contact PI
Neutrophil Biomarker and neutrophil targeted therapy to predict and prevent heterotopic ossification$408,750
R61 · FY2020 · AR · contact PI
Developing New Diagnostic and Timed, TAK1 Specific Treatment Strategies for Trauma Induced Heterotopic Ossification$301,380
R01 · FY2020 · GM · contact PI
Targeting Molecular and Cellular Mediators of Inflammation to Prevent Pathologic Cell Differentiation and Heterotopic Ossific$240,267
R01 · FY2020 · AR · contact PI
Targeting Molecular and Cellular Mediators of Inflammation to Prevent Pathologic Cell Differentiation and Heterotopic Ossification$55,185
R01 · FY2020 · AR · contact PI
Targeting Molecular and Cellular Mediators of Inflammation to Prevent Pathologic Cell Differentiation and Heterotopic Ossification$306,900
R01 · FY2019 · AR · contact PI
Developing New Diagnostic and Timed, TAK1 Specific Treatment Strategies for Trauma Induced Heterotopic Ossification$296,400
R01 · FY2019 · GM · contact PI
Targeting Molecular and Cellular Mediators of Inflammation to Prevent Pathologic Cell Differentiation and Heterotopic Ossification$306,900
R01 · FY2018 · AR · contact PI
Developing New Diagnostic and Timed, TAK1 Specific Treatment Strategies for Trauma Induced Heterotopic Ossification$296,400
R01 · FY2018 · GM · contact PI
Developing New Diagnostic and Timed, TAK1 Specific Treatment Strategies for Trauma Induced Heterotopic Ossification$59,406
R01 · FY2018 · GM · contact PI
Targeting Molecular and Cellular Mediators of Inflammation to Prevent Pathologic Cell Differentiation and Heterotopic Ossification$306,900
R01 · FY2017 · AR · contact PI
Developing New Diagnostic and Timed, TAK1 Specific Treatment Strategies for Trauma Induced Heterotopic Ossification$294,500
R01 · FY2017 · GM · contact PI
Novel Pathway and Prevention Strategy for Heterotopic Ossification$196,160
K08 · FY2017 · GM · contact PI
Novel Pathway and Prevention Strategy for Heterotopic Ossification$196,160
K08 · FY2016 · GM · contact PI
Novel Pathway and Prevention Strategy for Heterotopic Ossification$196,160
K08 · FY2015 · GM · contact PI
Novel Pathway and Prevention Strategy for Heterotopic Ossification$196,160
K08 · FY2014 · GM · contact PI
Enhancement Of Bone Regeneration From Human Adipose-Derived Stromal Cells$56,790
F32 · FY2010 · AR · contact PI
Enhancement Of Bone Regeneration From Human Adipose-Derived Stromal Cells$54,354
F32 · FY2009 · AR · contact PI